4.5 Review

Interface between normal and transformed epithelial cells: A road to a novel type of cancer prevention and treatment

Journal

CANCER SCIENCE
Volume 102, Issue 10, Pages 1749-1755

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1349-7006.2011.02011.x

Keywords

-

Categories

Funding

  1. Funding Program for Next Generation World-Leading Researchers (NEXT Program)
  2. Takeda Science Foundation
  3. Naito Foundation
  4. Sagawa Foundation for promotion of Cancer Research
  5. Yasuda Medical Foundation
  6. Ono Cancer Research Fund
  7. NOVARTIS Foundation (Japan) for the Promotion of Science
  8. Ichiro Kanehara Foundation
  9. Medical Research Council [MC_U122669938, MC_CF12266] Funding Source: researchfish
  10. MRC [MC_U122669938] Funding Source: UKRI

Ask authors/readers for more resources

Cell transformation arises from activation of oncoproteins and/or inactivation of tumor suppressor proteins. During the initial stage of carcinogenesis, transformation occurs in a single cell within an epithelial monolayer. However, it is not known what happens at the interface between normal and transformed cells once the initial transformation has occurred. Using elaborate cell culture systems, recent reports have shown that interactions between normal and transformed epithelial cells can induce various phenomena. For example, when Ras- or Src-transformed cells are surrounded by normal epithelial cells, multiple signaling pathways are activated and the transformed cells are apically extruded from the epithelium. In addition, normal and certain types of transformed cells compete with each other for cell survival, and the transformed cells undergo apoptosis. Importantly, when transformed cells alone are present, neither apoptosis nor elimination from epithelia occurs, indicating that the presence of surrounding normal cells influences the signaling pathways and fate of transformed cells. Comparable phenomena are also observed in zebrafish and mice in vivo model systems. In this review, I will introduce this newly emerging research field and discuss how these studies can potentially lead to establishment of novel types of cancer prevention and treatment. (Cancer Sci 2011; 102: 1749-1755)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available